SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-032807
Filing Date
2022-06-14
Accepted
2022-06-14 16:15:23
Documents
15
Period of Report
2022-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161570-8k_180life.htm   iXBRL 8-K 51872
2 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN ea161570ex10-1_180life.htm EX-10.1 118998
3 PRESS RELEASE DATED JUNE 14, 2022 ea161570ex99-1_180life.htm EX-99.1 15524
  Complete submission text file 0001213900-22-032807.txt   450600

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE atnf-20220614_def.xml EX-101.DEF 26891
5 XBRL LABEL FILE atnf-20220614_lab.xml EX-101.LAB 36930
6 XBRL PRESENTATION FILE atnf-20220614_pre.xml EX-101.PRE 25513
7 XBRL SCHEMA FILE atnf-20220614.xsd EX-101.SCH 3798
9 EXTRACTED XBRL INSTANCE DOCUMENT ea161570-8k_180life_htm.xml XML 5700
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 221015035
SIC: 2834 Pharmaceutical Preparations